MedPath
NMPA Approval

Moxifloxacin Hydrochloride Eye Drops

国药准字H20243437

April 7, 2024

Drug Information

盐酸莫西沙星滴眼液

眼用制剂

0.5%(5ml:25mg,按C₂₁H₂₄FN₃O₄计)

化学药品

April 7, 2024

Company Information

Applicant Company

辽宁省沈阳市沈北新区蒲南路158号

Manufacturing Company

沈阳市沈北新区辉山经济开发区沈北路176号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸莫西沙星滴眼液 - NMPA 批准文号 | MedPath